ANRO

Alto Neuroscience Stock Analysis

AI Rating

Good
  • Quality2/10
  • Growth↑ 6/10
  • Momentum↑ 9/10
Alto Neuroscience sales and earnings growth
ANRO Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 53.83%
  • FCF Y/Y↓ -12.45%
Alto Neuroscience gross and profit margin trends
ANRO Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -245.30%
Alto Neuroscience net debt vs free cash flow
ANRO Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -27.0

Alto Neuroscience stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗